According to Fortune Business Insights, the global ophthalmology PACS market was valued at USD 581.9 million in 2025. The market is expected to climb to USD 649.4 million in 2026 and reach USD 1,524.9 million by 2034, translating into a compound annual growth rate (CAGR) of 11.26% across the 2026–2034 forecast window. North America led global demand in 2025, accounting for roughly 41% of the total market.
Ophthalmology PACS solutions are specialized platforms built to store, organize, retrieve, and share eye-imaging data generated by devices such as optical coherence tomography (OCT) scanners, fundus cameras, and slit-lamp systems. By consolidating this imaging data in a single system, these platforms help hospitals and eye-care clinics cut down on manual record handling and support quicker clinical decision-making. Demand is being pushed higher by the growing volume of ophthalmic imaging tied to rising rates of glaucoma, diabetic retinopathy, and age-related macular degeneration.
Key Market Trends
A defining trend in the space is the move toward AI-ready imaging archives. As ophthalmology practices generate increasing volumes of OCT, fundus, angiography, and visual-field data, providers are gravitating toward PACS platforms capable of supporting longitudinal disease tracking and AI-driven analytics, since well-structured, searchable datasets are essential for training reliable algorithms. Illustrating this shift, INFINITT North America rolled out its ophthalmology image-management system at West Virginia University Hospital in mid-2026.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ophthalmology-pacs-market-118007
Market Drivers, Restraints, and Opportunities
Growth is primarily driven by the rising volume of diagnostic imaging generated across multiple devices and locations, which makes centralized PACS platforms increasingly necessary for efficient storage, comparison, and sharing of patient records. On the restraint side, interoperability gaps remain a persistent obstacle: ophthalmic devices from different vendors often vary in their DICOM support, complicating integration and raising implementation costs, particularly for smaller practices.
Tele-ophthalmology represents a significant growth opportunity, as remote screening and virtual eye-care models require secure, cloud-based image access and multi-location collaboration tools. A notable example is ZEISS Vision Care's 2025 investment in Ocumeda to expand tele-ophthalmology capabilities across Europe. On the challenge front, transitioning from familiar device-specific viewers to centralized PACS systems can create training burdens and temporary workflow disruption, particularly in smaller clinics with limited IT resources.
Segmentation Highlights
By component, software and platforms held the largest share in 2025, reflecting their central role in image storage, viewing, and workflow automation, while the services segment is projected to grow at a 9.05% CAGR. On-premise deployment led the market by deployment type, as many providers still prefer keeping sensitive imaging data within their own IT infrastructure, though cloud-based deployment is forecast to expand faster, at a 17.28% CAGR.
By application, retinal disease imaging and monitoring dominated, driven by the recurring imaging needs of chronic conditions like diabetic retinopathy. OCT imaging led among imaging modalities given its central role in retinal and glaucoma assessment. Integrated platforms outperformed standalone systems, as providers increasingly seek PACS solutions that connect seamlessly with EHR/EMR systems and other clinical workflows. By end user, specialty eye hospitals and ophthalmology clinics represented the largest segment, owing to their high daily imaging volumes.
Regional Outlook
North America remained the largest regional market, valued at USD 240.1 million in 2025, with the United States alone projected to reach approximately USD 249 million in 2026. Europe is expected to grow at a 10.57% CAGR, reaching about USD 166.5 million by 2026, supported by healthcare digitization initiatives. Asia Pacific, estimated at USD 148.0 million in 2026, is expanding on the back of rising diabetes-related eye disease and growing investment in eye-care infrastructure across China, India, Japan, and South Korea. Latin America and the Middle East & Africa are growing more gradually, aided by expanding urban hospital infrastructure and rising awareness of diabetic eye disease.
Competitive Landscape
The market features ophthalmic device manufacturers, enterprise imaging vendors, and specialized software providers competing on multimodal image storage, cloud connectivity, and AI-ready data management. Leading companies identified in the report include Carl Zeiss Meditec AG, Topcon Healthcare, Heidelberg Engineering GmbH, Optos plc, Haag-Streit Group, Canon Medical Systems, NIDEK, Sectra AB, INFINITT Healthcare, and Sonomed Escalon. Recent activity includes Optain Health's acquisition of EyePACS and EssilorLuxottica's acquisition of Ikerian AG (RetinAI) in late 2025, both aimed at strengthening AI and data-management capabilities in eye care.
Conclusion
The ophthalmology PACS market is positioned for steady expansion through 2034, propelled by rising imaging volumes, the shift toward AI-ready data infrastructure, and growing tele-ophthalmology adoption, even as interoperability and training-related hurdles continue to shape the pace of implementation across providers of varying size.